Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system.
about
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron diseaseRecombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron diseaseNeurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosisMultidisciplinary Interventions in Motor Neuron Disease.Adaptation of slow myofibers: the effect of sustained BDNF treatment of extraocular muscles in infant nonhuman primates.Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy.The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4.Dach2-Hdac9 signaling regulates reinnervation of muscle endplates.The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.Neurotrophic modulation of motor neuron development.Therapeutic developments in amyotrophic lateral sclerosis.Regulation of quantal secretion by neurotrophic factors at developing motoneurons in Xenopus cell cultures.Potentiation of quantal secretion by insulin-like growth factor-1 at developing motoneurons in Xenopus cell culture.
P2860
Q24197515-0F18D788-46C1-4F75-B6D3-054570266E89Q24242947-58B41B03-2437-4E2D-A874-96CD6AA4C3BBQ33985590-C9C21AF1-ACF2-43EA-BEA2-48794F9ADCB1Q34757963-D38A4BDB-C1ED-42D3-BAC9-EE59D4E64DA3Q35540066-A04CFE08-07AD-44BF-B198-73D9ED42E16DQ35623262-6B773012-72DC-4303-81A2-657DF68D51D5Q35726073-65CFF2BE-AE56-4554-AE10-29C111F2183FQ35971304-1E456970-EA4F-4DC3-BC8E-B54A425BB50AQ36094664-9CED53D1-AFCB-4334-90C1-86BA66D257A2Q36234276-1A9520D0-8ED2-40EF-AAD5-019A2E9C8FB5Q36462520-C44BA976-4220-4867-A3FF-7799E5C2250FQ36684355-6E254C15-3CAA-48B7-9076-8B7CC7DA038AQ37393565-E580BE6A-C0CF-42D0-AFBC-9633E5DE2743Q40408954-AE5680B6-3AB1-40D0-9E73-DDD624EEB204Q41093874-5285108E-C026-4D88-BD74-B62F261E65ADQ44599989-73741CF2-FFC8-4BEA-BA33-D0F8D48DB1B2
P2860
Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Activity-sensitive signaling b ...... nerating neuromuscular system.
@en
type
label
Activity-sensitive signaling b ...... nerating neuromuscular system.
@en
prefLabel
Activity-sensitive signaling b ...... nerating neuromuscular system.
@en
P2860
P1476
Activity-sensitive signaling b ...... nerating neuromuscular system.
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1993.TB26219.X
P407
P577
1993-08-01T00:00:00Z